What Does Glympse Bio Do?

Total employees80
HeadquartersCambridge
Founded2015

Glympse Bio is a biotechnology company at the forefront of developing a novel, tunable biosensor platform. Their technology aims to revolutionize disease detection and monitoring by non-invasively measuring protease activity directly in the body, which is a key indicator of disease. These activity-based biosensors are designed to provide real-time insights into disease progression and treatment response across a range of conditions, including oncology, fibrosis (like NASH), and immunology. By enabling earlier and more accurate diagnoses, Glympse Bio seeks to improve patient outcomes and facilitate personalized medicine.

Where Is Glympse Bio's Headquarters?

HQ Function

The Cambridge headquarters serves as the primary center for Glympse Bio's research and development, clinical operations, strategic partnerships, and corporate administration.

Notable Features:

Situated in the Kendall Square area, the facility likely includes state-of-the-art laboratories for biosensor development and testing, alongside modern office spaces designed to foster collaboration and innovation.

Work Culture:

The work culture at Glympse Bio's headquarters is expected to be dynamic, science-driven, and mission-focused, emphasizing collaboration, cutting-edge research, and a commitment to tackling significant healthcare challenges. Employees likely share a passion for translational medicine and patient impact.

HQ Significance:

Its location in Kendall Square provides Glympse Bio with unparalleled access to a rich ecosystem of academic institutions (like MIT and Harvard), research organizations, venture capital, and a highly skilled talent pool, crucial for a pioneering biotech company.

Values Reflected in HQ: The headquarters likely reflects Glympse Bio's core values of innovation, scientific excellence, collaboration, and a patient-centric approach to developing transformative medical technologies.

Location:

While Glympse Bio's physical operations are centered in the United States (Cambridge, MA), its scientific collaborations, potential clinical trial sites, and the ultimate application of its diagnostic technologies are global in scope. The company engages with international researchers and institutions and aims to address diseases that affect populations worldwide. Its investor base also includes international entities, indicating a global interest and reach.

Street Address:

245 First Street, Suite 1800

City:

Cambridge

State/Province:

MA

Country:

USA

Where Else Does Glympse Bio Operate Around the World?

N/A

Address: N/A

N/A

Buying Intent Signals for Glympse Bio

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Glympse Bio? Meet the Executive Team

As of April 2025, Glympse Bio' leadership includes:

Caroline J. Loew, PhD - President and Chief Executive Officer
Wendy Winckler, PhD - Chief Scientific Officer
Jorge DiMartino, MD, PhD - Chief Medical Officer
Ben Auspitz - Chief Strategy Officer
Pol N. F. H. M. Vandevoort - Chief Business Officer

Who's Investing in Glympse Bio?

Glympse Bio has been backed by several prominent investors over the years, including:

GV (Google Ventures)
Pfizer Ventures
Roche Venture Fund
Section 32
LS Polaris Innovation Fund
Alexandria Venture Investments
Casdin Capital
GreatPoint Ventures
Waterman Ventures
Catalio Capital Management
Gilead Sciences

What Leadership Changes Has Glympse Bio Seen Recently?

Hire0
Exits0

Glympse Bio has maintained a relatively stable core executive team recently, with key appointments made just outside the strict 12-month window bolstering its clinical and strategic leadership. No major C-suite departures have been publicly announced in the immediate past year.

New Appointments:

Jorge DiMartino, MD, PhD, Jorge DiMartino was appointed as Chief Medical Officer to lead clinical strategy and development.

What Technology (Tech Stack) Is Used byGlympse Bio?

Discover the tools Glympse Bio uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Glympse Bio Email Formats and Examples

Glympse Bio likely utilizes common corporate email formats. The most probable patterns involve combinations of first name, last name, and first initial.

[first_initial][last]@glympsebio.com (e.g., jdoe@glympsebio.com) or [first].[last]@glympsebio.com (e.g., jane.doe@glympsebio.com)

Format

cl Loew@glympsebio.com (example using first initial last name format for CEO)

Example

80%

Success rate

What's the Latest News About Glympse Bio?

Glympse Bio Press ReleaseJanuary 9, 2023

Glympse Bio Appoints Jorge DiMartino, M.D., Ph.D., as Chief Medical Officer

Glympse Bio announced the appointment of Jorge DiMartino, M.D., Ph.D., as Chief Medical Officer. Dr. DiMartino will lead the company's clinical strategy and development of its novel biosensor platform for non-invasive disease monitoring....more

Glympse Bio Press ReleaseNovember 1, 2022

Glympse Bio Appoints Wendy Winckler, Ph.D., as Chief Scientific Officer

Glympse Bio announced the appointment of Wendy Winckler, Ph.D., as Chief Scientific Officer. Dr. Winckler will lead the company’s research organization and oversee discovery and translational research for its pipeline of programs in oncology, fibrosis and infectious diseases....more

Glympse Bio Press ReleaseMay 10, 2022

Glympse Bio Announces First Patient Dosed in Phase 1 Study of Injectable Biosensors for Monitoring Treatment Response in Oncology

Glympse Bio announced that the first patient has been dosed in its Phase 1 clinical study evaluating the safety, tolerability and pharmacokinetics of its injectable biosensors for monitoring treatment response in cancer patients....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Glympse Bio, are just a search away.